Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.1 USD | +17.49% | +36.60% | +43.96% |
13/05 | Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
17/04 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.96% | 13.55M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Cerecor : COVID-19 Drug Gets FDA Fast Track Designation